Search results

Records found: 7  
Your query: Author Sysno/Doc.kind = "^sllk_un_auth d018631 xcla^"

  1. 1.Association of EGFR and KRAS mutations with expression of p-AKT, DR5 and DcR1 in non-small cell lung cancer

    Association of EGFR and KRAS mutations with expression of p-AKT, DR5 and DcR1 in non-small cell lung cancer  / X. D. Zhao ... [et al.] .  Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685 . - Vol. 64, no. 2 (2017), s. 182-191  : ilustr., grafy, tab.  
    C 720
    article

    article

  2. 2.Cetuximab plus chemotherapy as first-line treatment for metastatic colorectal cancer: Effect of KRAS mutation on treatment efficacy in Taiwanese patients

    Cetuximab plus chemotherapy as first-line treatment for metastatic colorectal cancer: Effect of KRAS mutation on treatment efficacy in Taiwanese patients  / M. C. Chen ... [et al.] .  Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685 . - Vol. 60, no. 5 (2013), s. 561-567  : ilustr., grafy, tab.  
    C 720
    article

    article

  3. 3.Insulin receptor, IRS1, IRS2, INSIG1, INSIG2, RRAD, and BAIAP2 gene expressions in glioma U87 cells with ERN1 loss of function: effect of hypoxia and glutamine or glucose deprivation

    Insulin receptor, IRS1, IRS2, INSIG1, INSIG2, RRAD, and BAIAP2 gene expressions in glioma U87 cells with ERN1 loss of function: effect of hypoxia and glutamine or glucose deprivation  / Minchenko D. O. ... [et al.] .  Endocrine regulations. - ISSN 1210-0668 . - Vol. 47, no. 1 (2013), s. 15-26  : ilustr., grafy, obr.  
    C 1685
    article

    article

  4. 4.Naděje v terapii metastazujícího melanomu, která však musí být dále evaluována?

    Naděje v terapii metastazujícího melanomu, která však musí být dále evaluována?  / Vykutilová, S., Pospíšilová, A. .  Derma 3. tisícročia : odborný časopis dermatovenerológie, estetickej dermatológie a kozmetiky. - ISSN 1335-7913 . - Roč. 8, č. 2-4 (2008), s. 66-68  : ilustr., obr.  
    C 3030
    article

    article

  5. 5.PIK3CA mutations are a predictor of docetaxel plus epirubicin neoadjuvant chemotherapy clinical efficacy in breast cancer

    PIK3CA mutations are a predictor of docetaxel plus epirubicin neoadjuvant chemotherapy clinical efficacy in breast cancer  / Y. Zhang ... [et al.] .  Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685 . - Vol. 61, no. 4 (2014), s. 461-467  : ilustr., obr., tab.  
    C 720
    article

    article

  6. 6.RASSF1A promotes radiosensitivity in nasopharyngeal carcinoma by promoting FoxO3a and inhibiting the Nrf2/TXNRD1 signaling pathway

    RASSF1A promotes radiosensitivity in nasopharyngeal carcinoma by promoting FoxO3a and inhibiting the Nrf2/TXNRD1 signaling pathway  / Yishimei Si ... [et al.] .  Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685 . - Vol. 70, no. 5 (2023), s. 633-644  : ilustr., fareb., grafy, obr.  
    C 720
    article

    article

  7. 7.Risk of statin therapy in elderly

    Risk of statin therapy in elderly  / Ginter E., Kajaba I. .  Bratislavské lekárske listy : international journal for biomedical sciences and clinical medicine. - ISSN 0006-9248 . - Vol. 117, no. 10 (2016), s. 555-556  : ilustr., graf, sch.  
    C 526
    article

    article



  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all